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Abstract
Control of gammaherpesvirus infections requires a complex, well orchestrated immune response regulated by positive and
negative co-signaling molecules. While the impact of co-stimulatory molecules has been addressed in various studies, the
role of co-inhibitory receptors has not been tested. The ITIM-bearing CEACAM1 is an inhibitory receptor expressed by a
variety of immune cells, including B, T and NK cells. Using Ceacam12/2 mice, we analyzed the in vivo function of CEACAM1
during acute and latent murine gammaherpesvirus 68 (MHV-68) infection. During acute lytic replication, we observed lower
virus titers in the lungs of Ceacam12/2 mice than in WT mice. In contrast, during latency amplification, Ceacam12/2 mice
displayed increased splenomegaly and a higher latent viral load in the spleen. Analysis of the immune response revealed
increased virus-specific antibody levels in Ceacam12/2 mice, while the magnitude of the T cell-mediated antiviral immune
response was reduced. These findings suggest that inhibitory receptors can modulate the efficacy of immune responses
against gammaherpesvirus infections.
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Introduction
Murine gammaherpesvirus 68 (MHV-68) is a natural pathogen of
wild murine rodents [1], and has recently been established as a mouse
model to study gammaherpesvirus pathogenesis [2,3]. In humans,
the prototypic c1-herpesvirus, Epstein-Barr virus (EBV), is associated
with lymphomas and nasopharyngeal carcinoma [4]. Human
Herpesvirus-8 (HHV-8, KSHV), a c2-herpesvirus, is associated with
lymphoproliferative disorders and Kaposi’s sarcoma [5].
Intranasal infection of mice with MHV-68 results in an acute,
productive infection in the lung with viral titers reaching the peak
around day 6, and clearance of lytic virus around day 10 to 14 post
infection, mainly by CD8+ T cells [6,7]. Latency is established by
virus traveling from the lung to the mediastinal lymph nodes. B cells
from the mediastinal lymph nodes then traffic to the spleen and
other lymphoid organs and establishment of life-long latency takes
place [6]. B lymphocytes are the major reservoir harboring latent
MHV-68 [8], but macrophages [9], dendritic cells [10] and lung
epithelial cells [11] have also been shown to harbor latent virus.
Memory B cells are the major reservoir for long term latency [12–
14]. The establishment of latency in the spleen is associated with a
marked splenomegaly and an increase in the number of splenocytes
which peaks around 2–3 weeks post-infection. This process is driven
by CD4+ T cells and depends on MHV-68-infected B cells in the
spleen [15]. The splenic mononucleosis is associated with a strong
increase in the number of latently infected B cells. Following the
amplification of latency, there is both a decrease of the
splenomegaly and of the number of latently infected splenocytes
back to a basal level [6]. Multiple immune mechanisms including
CD8+ T cells, CD4+ T cells and antibodies contribute to the control
of latency and preventing recrudescence of lytic virus [6,16,17].
The CEA-related cell adhesion molecule 1 (CEACAM1) is one of
the primordial members of the carcinoembryonic antigen (CEA)
family, which itself belongs to the immunoglobulin superfamily [18].
This highly glycosylated protein is abundantly expressed in
epithelia, vessel endothelia and leukocytes. In most CEACAM1-
expressing cell types, the molecule occurs in two major splice
variants differing in their cytoplasmic domain, called CEACAM1-L
and CEACAM1-S. The ‘L’-isoforms encompass approximately 70
amino acids in the cytoplasmic domain, including tyrosines that are
part of an immunoreceptor tyrosine-based inhibitory motif (ITIM)
and an immunoreceptor tyrosine-based switch motif (ITSM). After
tyrosine phosphorylation, CEACAM1-L can bind SH2 domain-
containing proteins, thereby activating Src-family tyrosine kinases
[19,20] and the protein tyrosine phosphatases SHP-1 and SHP-2
[21]. The ‘S’-isoforms encode 10 cytoplasmic residues without
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ITIM/ITSM motifs. CEACAM1-mediated signals regulate the
function of various immune cells. We and others have demonstrated
that CEACAM1 can amplify T cell responses under certain
conditions [22,23]. Likewise, targeting CEACAM1 with the mAb
AgB10 can enhance murine B cell proliferation through activation
of the c-Jun NH2-terminal kinase (JNK) pathway [24]. The same
mAb induces maturation and chemokine/cytokine secretion of
murine dendritic cells [25]. It was also shown that CEACAM1 can
inhibit signals delivered by immunoreceptor tyrosine-based activa-
tion motif (ITAM)-containing molecules [26–30]. Furthermore,
CEACAM1 can inhibit NK cell cytotoxicity when co-ligated with
NK cell-activating receptors [31]. These observations indicate that
CEACAM1 participates in the regulation of immune responses by
delivering signals, and modifying signals transduced by other
molecules [32]. Recently, Nagaishi and coworkers demonstrated
that in vivo, CEACAM1-L overexpression or deletion in T cells
resulted in T cell inhibition or activation, respectively [30].
Here, we took advantage of Ceacam12/2 mice to determine for
the first time the outcome of integrated CEACAM1 signaling
during the immune response to a naturally occurring gammaher-
pesvirus infection. Based on the results obtained by functional
analyses of CEACAM1 using purified immune cells one would
expect an enhanced NK, T and B cell response in Ceacam12/2mice,
favoring the control of MHV-68 infection. Although Ceacam12/2
mice displayed an enhanced control of the acute lytic MHV-68 lung
infection, the absence of CEACAM1 resulted in elevated viral loads
and increased splenomegaly during latency amplification.
Results
Lytic virus titers in the lungs are reduced in Ceacam12/2
mice
To analyze lytic replication, Ceacam12/2 and WT mice were
infected intranasally (i.n.) with 56104 PFU. This viral dose has
frequently been used by us for i.n. infection and is within the range
of doses which have been shown to result in stable levels of acute
and latent infection [33]. First, in a kinetic experiment, lungs were
harvested at various time points after infection and lytic virus titers
in lung homogenates were determined by plaque assay on BHK-
21 cells. Lungs of Ceacam12/2 mice contained significantly less
lytic virus when compared to WT mice (Fig. 1A). Next, we
analyzed additional animals on day 6 after infection, the time
point at which viral titers usually reach a peak. As in the kinetic
experiment, lungs of Ceacam12/2 mice contained significantly less
lytic virus when compared to WT mice (Fig. 1B). These data
suggested that Ceacam12/2 mice can control the acute infection
more efficiently than WT mice. There was no lytic virus detectable
in lung homogenates of both Ceacam12/2 and WT mice at day 42
after infection, even after in vitro amplification (Fig. 1A and data
not shown).
The latent viral load is increased in Ceacam12/2 mice
The establishment of latency in the spleen is associated with an
increase in the number of latently infected B cells which peaks
around 2–3 weeks after infection. To analyze the latent phase of
infection, mice were infected i.n. with 56104 PFU. The number
of latently infected splenocytes can be determined by measuring
the number of reactivating splenocytes in the ex vivo reactivation
assay and by evaluating the viral genomic load by quantitative
PCR. Thus, we determined the extent of ex vivo reactivation of
splenocytes at day 17 after infection. The frequency of ex vivo
reactivation of splenocytes isolated from Ceacam12/2 mice (1 in
1938) was significantly higher than in WT mice (1 in 6453;
Fig. 2A). Consistent with the data from the ex vivo reactivation
assay, the viral genomic load, as determined by quantitative
PCR, was significantly higher in Ceacam12/2 mice (164 copies of
viral gB gene per 1000 copies of the ribosomal protein gene L8) as
Figure 1. Virus titers in the lung are reduced in Ceacam12/2mice. A) In a kinetic experiment, mice were infected i.n. with 56104 PFU. At days
1, 3, 6, 8 and 42, lungs were harvested and virus titers of lung homogenates were determined by plaque assay on BHK-21 cells. Each symbol
represents a single mouse. The horizontal bars indicate the means. The difference between WT mice and Ceacam12/2 mice was statistically
significant (p = 0.001 by two-way ANOVA). B) Mice were infected i.n. with 56104 PFU. At day 6 after infection, lungs were harvested and virus titers
were determined as described in A. The mean viral titer in lungs of Ceacam12/2 mice (n = 11) was significantly lower than in control mice (n = 11)
(p = 0.01). The detection limit of the assay is indicated by the dashed line.
doi:10.1371/journal.pone.0006317.g001
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compared to WT mice (82 copies gB per 1000 copies L8) at day
17 after infection (Fig. 2B). At days 42 and 300 after infection, the
viral genomic load was not significantly different between the two
groups. These data demonstrated a higher number of latently
infected cells in Ceacam12/2 mice when compared to WT
mice.
CEACAM1 expression on splenic B and T cells changes
only marginally during infection
As expected, strong expression of CEACAM1 was observed on
granulocytes of WT mice but not of Ceacam12/2 mice (Fig. 3A). In
WT mice, CEACAM1 was also strongly expressed on B cells while
it was undetectable on T cells. CEACAM1 expression was
unaltered on different leukocyte populations during MHV-68
infection (Fig. 3B and data not shown), with the exception of a
marginal downregulation of CEACAM1 on B cells at day 17 p.i.
(Fig. 3B).
Increased splenomegaly and unique changes of spleen
cell composition during MHV-68 infection of Ceacam12/2
mice
The establishment of latency in the spleen is associated with a
marked splenomegaly which peaks around 2–3 weeks after
infection. Thus, we first determined the extent of splenomegaly
at different time points after infection. Both at day 17 and 42 after
infection, Ceacam12/2 mice showed a significantly higher spleen
weight than WT mice (Fig. 4A). Similar to the spleen weight, the
total number of spleen cells was significantly higher in Ceacam12/2
mice than in WT mice at day 17 (1.94 fold) and at day 42 (1.90 fold)
after infection (data not shown). Second, we characterized the
lymphocyte subpopulations in the spleen at days 6, 17 and 42 p.i..
At day 6 p.i., no significant differences concerning the composition
of the lymphocyte subpopulations were observed between Cea-
cam12/2 and WT mice (Fig. 4B). At day 17 p.i., the proportion of
CD3+ and CD8+ T cells was increased in WT mice compared to
Ceacam12/2 mice whereas the proportion of CD19+ and CD4+ cells
was decreased. This was even more pronounced at day 42 p.i.
(Fig. 4B). In both mouse lines, the proportion of CD62Lhigh T cells
strongly decreased during infection. However, the decrease was
significantly stronger in WT mice than in Ceacam12/2mice (Fig. 4B).
The absolute cell numbers of the lymphocyte subpopulations
(calculated using total splenocyte numbers and the proportions of
the subpopulation) revealed that all lymphocyte subpopulations
with the exception of CD62Lhigh T cells (where absolute cell
numbers actually decreased in WT mice) increased more strongly in
Ceacam12/2 mice than in WT mice between day 6 and day 17 p.i.,
with the difference being most prominent for B cells and least
pronounced for CD8+ T cells (Fig. 4C). At day 42 post infection, the
numbers of B cells and CD4+ T cells were still higher in Ceacam12/2
mice than in WT mice, while the number of CD8+ T cells was
nearly identical in both mouse strains (Fig. 4C). Interestingly, while
WT mice had almost no naı¨ve (CD62Lhigh) T cells at day 42 p. i.,
Ceacam12/2mice displayed naı¨ve T cell numbers comparable to the
level at day 6 p.i. (Fig. 4C).
The frequency of virus-specific CD8+ T cells is
significantly reduced in Ceacam12/2 mice
To investigate the virus-specific T cell response, we determined
the frequency of IFN-c-producing CD8+ T cells in the spleens of
infected mice upon in vitro restimulation with epitope-specific
peptides (Fig. 5). Two epitopes were chosen which exhibit a
different expression pattern during virus infection. ORF6 is
Figure 2. Ex vivo virus reactivation and viral genomic load are increased in Ceacam12/2 mice. A) Ex vivo reactivation of splenocytes. Mice
were infected i.n. with 56104 PFU of MHV-68. At the indicated time points after infection, spleens were harvested and single splenocyte suspensions
were prepared and analyzed in the ex vivo reactivation assay. Data shown in panel A are means6SEM pooled from three independent experiments. In
each experiment, splenocytes from 3 to 5 mice per group were pooled. The dashed line in panel A indicates the point of 63.2 % Poisson distribution,
determined by nonlinear regression, which was used to calculate the frequency of cells reactivating lytic MHV-68 replication. To calculate significance,
frequencies of reactivation events were statistically analyzed by paired t-test over all cell dilutions. The statistical significance of the difference
between WT and Ceacam12/2 mice is p = 0.02. B) Viral genomic load. Mice were infected i.n. with 56104 PFU of MHV-68. At days 17, 42 and 300 after
infection, spleens were harvested, single splenocyte suspensions were prepared and used for DNA isolation for real time PCR analysis. The data are
presented as viral genome copy numbers (as determined by quantitation of the copy number of the MHV-68 gB gene) relative to the copy number of
the murine ribosomal protein L8 gene (Rpl8). Data shown are means6SD of 14 mice per group at day 17, 8 mice per group at day 42 and 2–3 mice
per group at day 300.
doi:10.1371/journal.pone.0006317.g002
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Figure 3. CEACAM1 expression on splenic B and T cells changes only marginally during infection. Mice were infected i.n. with 56104
PFU of MHV-68. At days 0, 6, 17 and 42 after infection, CEACAM1 expression by spleen cells was determined by three color flow cytometry. The
indicated cells were labeled either with the CEACAM1-specific mAb CC1 (open curves) or an isotype-matched antibody (filled curves). A) Granulocytes
from Ceacam12/2 and WT mice were gated according to their characteristic forward/sideward scatter (verified by anti-GR1 (Ly6G) staining) and
analysed for CEACAM1 expression. B) CEACAM1 expression on lymphocyte subpopulations from WT mice at different time points after infection. Cells
were gated for expression of CD19 (B cells; left panel) and for expression of CD3 (T cells; right panel). The mean fluorescence intensity (mfi) is
indicated by numbers (mfi isotype control/mfi specific staining). The experiment was repeated three times with similar results.
doi:10.1371/journal.pone.0006317.g003
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expressed only during lytic infection while ORF61 is mainly
expressed in the spleen during establishment of latency [34–36].
As shown in Fig. 5B (upper panel), the frequency of ORF6-specific
IFN-c-producing CD8+ T cells was significantly lower in
Ceacam12/2 mice, as compared to WT mice, both on days 17
and 42 p.i.. The lower frequency of ORF6-specific CD8+ T cells in
Ceacam12/2 mice was partially compensated by their higher total
number on day 17 but not on day 42 p.i. (Fig. 5B, lower panel).
There was also a reduced number of ORF61-specific IFN-c-
producing CD8+ T cells at day 42 p.i. in Ceacam12/2 mice.
However, this difference did not reach statistical significance.
Taken together, the extent of the early virus-specific T cell
response is similar in the two mouse strains but the duration or
maintenance of the virus-specific T cell response is reduced in
Ceacam12/2 mice, when compared to WT mice.
Ceacam12/2 mice show a stronger virus-specific
antibody response than WT mice
To investigate the humoral immune response, we analyzed the
virus-specific antibody levels in sera of infected mice. At days 6, 17
and 42 after infection, serum was prepared from blood and used in
a virus neutralization assay. At day 6 after infection, the levels of
virus-specific antibodies in Ceacam12/2 and WT mice were below
the detection limit of the assay (data not shown). Virus-specific
antibodies were detectable at day 17 p.i. and their amount further
increased until day 42 p.i. in both mouse groups. The levels of
virus-specific antibodies were significantly higher in Ceacam12/2
mice compared to WT mice, as determined by two-way analysis of
variance (ANOVA) (Fig. 6A).
The immune response in Ceacam12/2 mice shows a
trend towards lower IFN-c but higher IL-5 levels
The weaker virus-specific T cell but stronger humoral
immune response of Ceacam12/2 mice, when compared to WT
mice, suggested that the immune response of Ceacam12/2 mice
might be shifted towards a type2 response. To test this
hypothesis, we analyzed the levels of IFN-c and IL-5 in sera of
infected mice at different time points after infection. Although
there was considerable variation between individual mice in
both groups, we indeed observed a trend towards lower IFN-c
but higher IL-5 levels in sera of infected Ceacam12/2 mice, when
compared to infected WT mice, as reflected by the lower IFN-c
Figure 4. Splenomegaly and composition of spleen cells during MHV-68 infection differ in Ceacam12/2 and WT mice. A)
Splenomegaly. Mice were infected i.n. with 56104 PFU of MHV-68. At the indicated time points after infection, spleen weights were determined. Data
shown in panel A are means6SD of 5 mice (day 6), 11 mice (day 17), 8 mice (day 42) and 3 mice (day 300). Data from uninfected (naive) mice are
shown for comparison (n = 24 for WT and n= 13 for Ceacam12/2 mice). B) Mice were infected i.n. with 56104 PFU of MHV-68. At days 6, 17 and 42
after infection, the immunophenotype of spleen cells was determined by three color flow cytometry. In each experiment, three mice were used per
group, and the experiments were repeated twice (day 6 p.i.) and three times (days 17 and 42 p.i.), respectively. For determination of the percentage
of CD3 and CD19 positive cells, only cells within the lymphocyte forward/sideward scatter gate were accepted. For all other markers (indicated by the
blue box), only CD3+ cells were accepted. CD62Lmedium cells are not depicted. Asterisks denote statistically significant differences between WT and
Ceacam12/2 mice (*: p , 0.05; **: p , 0.01). C) The absolute cell numbers were calculated as follows: number of cells = number of lymphocytes per
spleen6living cells (%) / 100.
doi:10.1371/journal.pone.0006317.g004
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Figure 5. Ceacam12/2mice develop a significant weakerMHV-68-specific CD8+ T cell immune response during infection thanWTmice.Mice
were infected i.n. with 56104 PFU of MHV-68. Spleen cells (36106/mL) obtained on days 17 and 42 p.i. were restimulated with MHV-68 ORF6- and ORF61-
deduced peptides prior to intracellular staining for IFN-c. Double-positive (CD8+ IFN-c+) cells were peptide-specific T cells. A) Dotplots of a representative
experiment (ORF6 at day 17) with controls (without addition of peptides or after stimulation with anti-CD3 mAb). The mean numbers of double-positive CD8+
IFN-c+ T cells per 105 CD8+ spleen cells6SD of three individual mice (upper panel) and themean number of double-positive CD8+ IFN-c+ T cells per spleen6SD
of three individual mice (lower panel) are shown. The p values for the differences between Ceacam12/2 and WT mice are indicated.
doi:10.1371/journal.pone.0006317.g005
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to IL-5 ratios in Ceacam12/2 mice at days 6 and 8 after infection
(Fig. 6B).
The expression of CEACAM1 increases after infection of
WT mice with MHV-68
The finding that Ceacam12/2 mice displayed a reduced virus-
specific T cell response (Fig. 5), yet controlled the acute lung
infection more efficiently than WT mice (Fig. 1), as well as the
observation that CEACAM1 can inhibit NK cell cytotoxicity
when co-ligated with NK cell-activating receptors [31], prompted
us to investigate the expression of CEACAM1 in the lungs of
Ceacam12/2 and WT mice by immunohistochemistry. As
expected, no CEACAM1 expression could be detected in lungs
of uninfected and infected Ceacam12/2 mice (Fig. 7A and B). In
contrast, CEACAM1 expression was readily detectable in
uninfected WT mice and was upregulated after infection,
especially in bronchial epithelial cells (Fig. 7C and D).
Discussion
In this study, we investigated the role of the inhibitory molecule
CEACAM1 in the immune response to MHV-68 infection using
Ceacam12/2 mice. When compared to WT mice, Ceacam12/2
mice had lower virus titers in the lungs during acute lytic
replication. At day 17 p.i., Ceacam12/2 mice displayed increased
splenomegaly and a higher latent viral load in the spleen as
determined both by ex vivo reactivation assay and quantitative
PCR. At day 42 p.i., Ceacam12/2 mice still displayed increased
splenomegaly. Disparities in the immune response to MHV-68
infection were also observed. At days 17 and 42 p.i., Ceacam12/2
Figure 6. Ceacam12/2 mice show stronger virus-specific antibody responses and exhibit lower IFN-c but higher IL-5 serum levels in
comparison to WT mice. A) Mice were infected i.n. with 56104 PFU of MHV-68. At days 17 and 42 after infection, blood was collected and serum
was prepared and used in a virus neutralization assay. Data shown are means6SD compiled from two to four independent experiments. In each
experiment, sera from 3 to 5 mice per group were pooled. Statistical analysis was performed using two-way ANOVA. The differences of the antibody
levels were statistically significant between the two mouse strains, as indicated in the figure, as well as between the two time points. B) Mice were
infected i.n. with 56104 PFU. At days 3, 6 and 8 after infection, cytokine levels in sera were determined by ELISA. Ratios were calculated on the basis
of the raw data shown in C and D. Each symbol represents a single mouse. The horizontal bars indicate the means.
doi:10.1371/journal.pone.0006317.g006
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mice displayed, when compared to WT mice, an aberrant
lymphocyte subset composition in the spleen and a reduced
frequency of MHV-68-specific CD8+ T cells. In contrast, higher
levels of virus-specific antibodies were observed in Ceacam12/2
mice. In addition, Ceacam12/2 mice showed a cytokine profile
suggestive for a shift towards a Th2 type immune response.
So far, no reports investigating the role of inhibitory receptors
during MHV-68 infection are available. However, using MHV-
68, the role of several co-stimulatory molecules in the control of
and the immune response to acute and chronic gammaherpesvirus
infections has been investigated [37]. Both CD40 and CD40L
have been shown to be dispensable for the control of acute
infections but to be important for the long-term control of MHV-
68 [38–40]. CD28 is required for an effective humoral immune
response to MHV-68 but not for acute or long-term T cell
responses, and CD282/2 mice can control the virus [39,41]. CD80
and CD86 single-knockout mice are able to control MHV-68
infection, while CD80/CD86 double-knockout mice fail to
maintain efficient long-term control of MHV-68, demonstrating
that these molecules play overlapping roles in the control of MHV-
68 [42,43]. In CD802/2/CD862/2 mice, primary antiviral CD8+
T cell responses and the induction of neutralizing antibodies are
impaired [42,43]. The 4-1BBL/4-1BB costimulatory pathway was
recently found to be important for the maintenance of antiviral
CD8+ T cell function during latent MHV-68 infection [44].
Compared to the co-stimulatory molecules CD28, CD40,
CD40L, CD80/CD86 and 4-1BBL, CEACAM1 seems to play a
different role during MHV-68 infection (Table 1). During acute
replication in the lungs, the absence of CEACAM1 resulted in
lower viral titers. We hypothesize that this may be due to an
increased activity of NK cells since it has been shown that
CEACAM1 can inhibit NK cell cytotoxicity when co-ligated with
NK cell-activating receptors [31]. In WT mice, lung epithelial cells
indeed upregulated CEACAM1 early during infection (Fig. 7C
and D), suggesting that the absence of CEACAM1 in Ceacam12/2
mice promotes NK cell activity while in WT mice, the strong
expression of CEACAM1 downregulates NK cell activity.
Expression of CEACAM1 by NK cells, in particular after
activation, has been shown by others [45]. Clearly, much work
needs to be done to confirm our hypothesis. It would be
remarkable if in Ceacam12/2 mice, NK cells would contribute to
the clearance of lytic virus since this would be different to the
situation in other strains of mice where it has been reported that
NK cells are not involved in gammaherpesvirus clearance [46,47].
The absence of CD28, CD40, CD40L, CD80/CD86 or 4-
1BBL did either not affect viral replication in the early phase of
infection or early viral titers were rather increased [38,39,41–44].
In addition, in the absence of CD40, CD40L or CD80/CD86,
viral reactivation in the lungs was observed at later time points
after infection. In contrast, we did not detect viral reactivation in
Figure 7. Upregulation of CEACAM1 in lungs of infectedWTmice. CEACAM1 expression was visualized in lung sections by staining with mAb
CC1, followed by peroxidase-conjugated secondary antibody. CEACAM1 was neither expressed in uninfected Ceacam12/2 mice (A, insert in A) nor in
MHV-68-infected Ceacam12/2 mice (B, insert in B). In uninfected WT mice, CEACAM1 was readily detectable on immune cells (solid arrows) and on
alveolar cells but not or only marginally on bronchial epithelial cells (open arrows) (C). After MHV-68 infection, airway epithelial cells strongly
upregulated CEACAM1 (D, arrows and insert in D). Bars, 200 mm (A-D), 50 mm (insert in A-D). a, aveolar cells; b, bronchial epithelial cells.
doi:10.1371/journal.pone.0006317.g007
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the lungs of Ceacam12/2 mice 42 days after infection. While we
detected increased splenomegaly and a higher splenic latent viral
load in Ceacam12/2 mice at day 17 after infection, a similar
genomic load in the spleens of WT and Ceacam12/2 mice was
detected at days 42 and 300 after infection. This again is contrary
to MHV-68 infections in the absence of CD40, CD40L or CD80/
CD86, where splenomegaly and/or viral load during latency
amplification were either similar or lower [38,39,41–43]. The
overall higher genomic load during early latency around day 17 in
Ceacam12/2 mice was not only due to a higher total number of
cells as well as B cell numbers but also to an increased frequency of
latently infected cells, the existence of the latter most likely being
the consequence of the reduced frequency of MHV-68-specific
CD8+ T cells.
With regard to the immune response to MHV-68, we also noted
a number of differences between the role of CD28, CD40, CD40L
and CD80/CD86, and that of CEACAM1. We observed an
aberrant lymphocyte subset composition in the spleen of MHV-68
infected Ceacam12/2 mice, while the lymphocyte subset distribution
was unaltered in mice lacking CD28 or CD80/CD86 [39,43]. The
absence of CEACAM1 resulted in a reduced frequency of MHV-
68-specific CD8+ T cells. For mice lacking CD80/CD86, one study
reported an impaired primary expansion of MHV-68-specific CTLs
[42], while in another study, the frequency of MHV-68-specific
CTLs was unaffected by the lack of CD80/CD86 [43]. In the
absence of CD28 or CD40L, the frequency of MHV-68-specific
CTLs was unaltered [38,39,41]. Furthermore, the absence of
CD28, CD40 or CD80/CD86 resulted in a reduced production of
MHV-68-specific antibodies [37,39,41–43], whereas we observed
higher levels of virus-specific antibodies in Ceacam12/2 mice.
Taken together, the results obtained in Ceacam12/2 mice
support the view that a main function of CEACAM1 expressed by
lymphocytes is to regulate their proliferation. Thus, the absence of
CEACAM1 resulted in a more severe splenomegaly which could
be due to increased proliferation and/or enhanced recruitment of
cells. Indeed, the abnormal increase in absolute numbers of certain
lymphocytes correlated with the amount of CEACAM1 on
lymphocytes of the different subpopulations. B cells which
constitutively express CEACAM1 were most abundant in
Ceacam12/2 mice after infection. In contrast, CD8+ T cells which
express CEACAM1 only for a certain time span upon activation
[48] increased much less. Greicius and coworkers reported that
CEACAM1-mediated signals, induced by cross-linking with anti-
CEACAM1 antibodies, facilitate B cell proliferation and antibody
production [24]. Whether this apparent discrepancy is due to
differences of in vitro as opposed to in vivo B cell stimulation or to
additional regulatory cells present in vivo has to be elucidated. The
different effects of CEACAM1-mediated growth control on B
versus T cells may lead to a bias of the immune response.
Alternatively, signaling through CEACAM1 may directly regulate
the bias of the immune response by facilitating a Th1 immune
response. This is supported by our previous observation that
CEACAM1 signaling in murine DC facilitates MHC-II-restricted
priming of naı¨ve CD4+ T cells with a Th1-biased polarization
[25]. Therefore, in the absence of CEACAM1, a type2 immune
response might be favored, as indicated by the higher titer of virus-
specific antibodies, the lower level of virus-specific CD8+ T cells
and the trend towards a decreased IFN-c to IL-5 ratio.
Since we analyzed the consequences of the complete absence of
CEACAM1 isoforms on the course of a gammaherpesvirus
infection, we cannot attribute the observed effects to a specific
isoform of CEACAM1. However, the fact that CEACAM1-L
exceeds the levels of CEACAM1-S in immune cells [49], and that
the inhibitory function of CEACAM1-L overrules the function of
the short isoform [32], indicates that the alterations of the immune
response are mainly due to the absence of CEACAM1-L.
What is the underlying mechanism of the reduced virus-specific T
cell response in Ceacam12/2 mice during the latent phase of MHV-
68 infection? One possibility is that the negative signal provided by
CEACAM1 during the early phase of the immune response may
prevent an overwhelming T cell activation in WT mice. Loss of
CEACAM1, therefore, could result in exhausted T cells that cannot
further control chronic virus infection [50]. Our experiments which
identified CD8+ T cell responses to an ‘‘early’’ and a ‘‘late’’ T cell
epitope suggest that the survival time of T cells which are activated
in the absence of a co-inhibitory molecule may be shorter and,
hence, the control of long lasting infections may be impaired.
In summary, due to an altered immune response, Ceacam12/2
mice displayed an enhanced control of the acute lytic MHV-68
lung infection but elevated splenic viral loads and increased
splenomegaly during latency amplification. Therefore, interfer-
ence with CEACAM1 function during gammaherpesvirus infec-
tions of humans, perhaps in combination with interference with
other inhibitory receptors, might have clinical value in the future.
Materials and Methods
Cell lines and virus stocks
BHK-21 cells were grown in Glasgow-MEM (Biochrom AG,
Berlin, Germany) supplemented with 5% fetal calf serum (FCS),
Table 1. Role of co-stimulatory and inhibitory receptors during MHV-68 infection.
Mouse strain Acute viral load (lung) Latent viral load (spleen) early/late Spleno-megaly Viral re-activation (lung) References
CD40 -/- = Q/ = Q yes 37,39,40,57
CD40L -/- = Q/ = Q yes 37,38
CD28 -/- = or q = / = = no 37,39,41,43
CD80 -/- = = / = = no 42,43
CD86 -/- = = / = = no 42,43
CD80/86 -/- = = / = = yes 42,43
4-1BBL -/- = = /q = no 44
CEACAM1 -/- Q q/ = q no this study
= , similar; q, increased; Q, decreased (compared to wildtype mice).
doi:10.1371/journal.pone.0006317.t001
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5% tryptose phosphate broth, 2 mM L-glutamine, 100 U/mL
penicillin and 100 mg/mL streptomycin. NIH3T3 cells were
grown in DMEM High Glucose (Cell Concepts, Umkirch,
Germany) supplemented with 10% FCS, 2 mM L-glutamine,
100 U/mL penicillin and 100 mg/mL streptomycin. The original
stock of MHV-68 (clone G2.4) was obtained from Drs. J. Stewart
and A. Nash (University of Edinburgh, Edinburgh, UK). Working
stocks of virus were prepared as previously described [51]. Briefly,
stocks were grown by infecting BHK-21 cells. After showing
complete cytopathic effect (CPE), BHK-21 cells were harvested
and the supernatant was used as working stock after two times
freezing/thawing the cells and removing cell debris by centrifu-
gation. Virus titers were determined by plaque assays. Briefly, 10-
fold dilutions were incubated on BHK-21 cells for 90 min at 37uC.
After removing the inoculum, cells were incubated for 5 days at
37uC with fresh medium containing methylcellulose. Cells were
stained with 0.1% crystal violet solution to determine the number
of plaques.
In vivo experiments
Ceacam12/2 mice and WT littermates were generated as
described previously [52] and bred under standard pathogen-free
conditions in the animal facility of the Helmholtz Zentrum
Mu¨nchen. Anesthetized mice were infected i.n. with 56104 plaque
forming units (PFU) of MHV-68. To determine lytic virus titers,
the lungs were harvested on various days after i.n. infection and
homogenized. After two times freezing and thawing the homog-
enates, plaque assays were performed with 10-fold dilutions of the
supernatants on BHK-21 cells. In vitro amplification of viral titers
was performed as described by others [42]. To determine the
frequency of cells carrying virus reactivating from latency, spleens
were harvested, single splenocyte suspensions were prepared and
analyzed in an ex vivo limiting dilution reactivation assay as
described [53]. Briefly, serial threefold dilutions of infected mouse
splenocytes were plated on monolayers of 16104 low-passage
NIH3T3 cells per well in 96-well tissue culture plates. 24 wells
were plated per dilution (starting with 1,56105 cells/well).
NIH3T3 cells were screened microscopically for a viral cytopathic
effect (cpE) for up to 3 weeks. To differentiate between latently
infected cells and infectious virus in the samples, serial threefold
dilutions of spleen cells were plated before or after mechanical
disruption of viable cells (by two freeze-thaw cycles). No infectious
virus was detected in samples of mechanically disrupted cells (data
not shown). Frequencies of reactivating cells were calculated on
the basis of the Poisson distribution by determining the cell
number at which 63.2% of the wells scored positive for CPE. All
animal experiments were in compliance with protocols approved
by the local Animal Care and Use Committee.
FACS analysis
For surface staining, cells were suspended in PBS/0.3% w/v
BSA supplemented with 0.1% w/v sodium azide. Nonspecific
binding of antibodies to Fc receptor was blocked by preincubating
cells with 1 mg anti-CD16/CD32 mAb 2.4G2/106 cells. Cells
were incubated with 0.5 mg/106 cells of the relevant mAb for
30 min at 4uC, washed twice, and subsequently incubated with a
second-step reagent for 15 min at 4uC. Cells were washed twice,
fixed with 2% paraformaldehyde for 1 h and analyzed on a
FACScan (Becton & Dickinson, Mountain View, CA). The
following reagents and mAbs from Pharmingen were used:
FITC-conjugated and APC-conjugated anti-CD3; FITC-conju-
gated and PE-conjugated anti-CD4; FITC-conjugated and PE-
conjugated anti-CD8; FITC-conjugated and PE-conjugated anti-
CD11c; PE-conjugated and allophycocyanin (APC)-conjugated
anti-CD19; PE-conjugated anti-CD25; PE-conjugated anti-
CD62L; PE-conjugated anti-CD69; APC-conjugated anti-NK-
1.1; FITC-conjugated anti-GR-1. Furthermore, we used FITC-
conjugated IgG1 mAb R3-34, PE-conjugated IgG1 mAb R3-34.
Expression of CEACAM1 was analysed using mAb CC1 (provided
by Kathryn V. Holmes, Aurora, CO, USA) and FITC-conjugated
and PE-conjugated rat anti-mouse IgG1 mAb (A85-1).
Intracellular cytokine staining assay
Spleen cells (106/mL) were incubated for 60 min in RPMI
medium with 5 mg/mL ORF61524-531/H2-Kb (TSINFVKI) or
ORF6487–495/H2-D
b (AGPHNDMEI) peptide (GENOVAC
GmbH, Freiburg, Germany) in round bottom 96-well plates.
Thereafter, 5 mg/mL brefeldin A (BFA) (Sigma) was added, and
the cultures were incubated for another 4 h. Cells were harvested
and surface-stained with PE-conjugated anti-CD8 mAbs (Phar-
mingen). Surface-stained cells were fixed with 2% paraformalde-
hyde in PBS before intracellular staining for IFN-c was performed.
Fixed cells were resuspended in permeabilization buffer (HBSS,
0.5% BSA, 0.5% saponin, 0.05% sodium azide) and incubated
with FITC-conjugated anti-IFN-c mAb (Pharmingen) for 30 min
at RT and washed twice in permeabilization buffer. Stained cells
were resuspended in PBS/0.3% w/v BSA supplemented with
0.1% w/v sodium azide and analyzed by flow cytometry. The
number of IFN-c+ cells per 105 CD8+ cells was determined. For
control of antigen-independent IFN-c production we did not add
any peptide to spleen cells, since previous experiments showed that
this control is equivalent to the addition of H2-Kb-restricted
peptides of irrelevant antigens.
Measurement of virus-specific antibody responses
Virus-specific antibodies in sera of infected mice were
determined by virus neutralization assays. Eight twofold dilutions
of serum were made, starting at a 1/20 dilution. The diluted
serum samples were mixed with 50 PFU of MHV-68 and
incubated on ice for 1 h. One hundred mL of each dilution were
then added in quadruplicate to NIH3T3 cells in 96 well plates and
incubated at 37uC. After 4 to 5 days, the wells were scored for
CPE. The serum neutralization titer was calculated by the method
of Reed and Muench [54].
Measurement of latent viral load by quantitative real
time PCR
Latent viral load in the spleens of infected mice was quantified
by real-time PCR using the ABI 7300 Real Time PCR System
(Applied Biosystems, Foster City, CA, USA). Amplification was
performed with Taqman universal PCR master mix and universal
cycling conditions (Applied Biosystems). Quantification of viral
DNA copy number was achieved by amplification of a 70 bp
region of the MHV-68 gB gene using primers and probes as
described by others [55]. A standard curve was generated using
known amounts of a plasmid containing the HindIII-N fragment of
MHV-68 (containing the gB gene). DNA was extracted from
spleen cells using the QIAamp DNA Mini Kit (Qiagen, Hilden,
Germany) and quantified by UV spectrophotometry. One
hundred ng of DNA were used per reaction. Although the assay
was able to detect less than 10 viral genomes per sample as
determined by spiking DNA from the spleen of an uninfected
mouse with a graded number of copies of the plasmid containing
the HindIII-N fragment of MHV-68, constant quantification was
possible at 50 or more copies per sample. Thus, in accordance
with published recommendations [56], the quantification limit was
set at 50 copies per sample. For statistical analysis, samples with a
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calculated copy number below 50 were assigned 50 copies. A
fragment of the murine ribosomal protein L8 gene (Rpl8) was
amplified using the Taqman gene expression assay (Assay ID:
Mm00657299_g1) (Applied Biosystems) and used to normalize for
input DNA between samples. A standard curve for Rpl8 was
constructed by serial dilution of a plasmid containing Rpl8 (RZPD
clone IRAVp968B01123D6) (RZPD, Berlin, Germany). The data
are presented as viral genome copy numbers relative to the gene
copy numbers of Rpl8.
Measurement of cytokines
Levels of IFN-c and IL-5 in sera of mice were determined by
ELISA using recombinant cytokine standards and pairs of capture
and biotin-conjugated secondary antibodies (Pharmingen, San
Diego, CA) according to the instructions of the manufacturer.
Histopathological analysis of lung tissue
Lungs of mice were harvested on day 6 after i.n. infection and
fixed in 10% formalin in PBS. For histopathological analysis,
organs were embedded in paraffin. Sections were cut, stained with
hematoxylin and eosin (H/E) and analyzed by light microscopy.
To visualize expression of CEACAM1, sections were stained with
mAb CC1, followed by reagents of mouse-to-mouse IHC
Detection kit (Millipore, Billerica, MA).
Statistical methods
If not otherwise indicated, data were analyzed by two-tailed
Student’s t-test.
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